KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY (EIN 841326605) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1972

Legal Domicile

Principal Officer

JAMIE M BAUMGARTNER

Phone

9702621230

Tax Period

2024-07-01 to 2025-06-30

KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY, founded in 1972, is a mid-sized nonprofit in the Science & Technology sector that reported $11.4M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year. Expenses of $12.9M exceeded revenue, resulting in a 13% operating deficit.

Mission

PROMOTION OF SCIENTIFIC EDUCATION

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,192,849

Program Service Revenue $8,607,692

Investment Income $560,796

Other Revenue $10,000

TOTAL REVENUE $11,371,337

Expense Breakdown

Grants Paid $569,089

Salaries & Benefits $3,985,238

Fundraising Expenses $781,243

Program Expenses $8,556,266

Other Expenses $8,341,549

TOTAL EXPENSES $12,895,876

Year-over-Year Comparison

	2024	2023	Change
Revenue	$11,371,337	$12,101,803	-0.1%
Expenses	$12,895,876	$12,109,586	+0.1%
Net Income	$-1,524,539	$-7,783	+194.9%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,053,008

Total Directors

$551,753

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMIE M BAUMGARTNER	PRESIDENT & CEO (FROM 7/24)	40.00	Officer Director	$154,153	$16,912	$171,065
WALTER H MOOS PHD	CHAIR OF BOARD	5.00	Officer Director	$0	$0	$0
MARGARET A GOODELL PHD	SECRETARY	3.00	Officer Director	$0	$0	$0
IAN M COLRAIN PHD	TREASURER	3.00	Officer Director	$0	$0	$0
CHERIE L BUTTS PHD	DIRECTOR	1.00	Director	$0	$0	$0
MORRIS J BIRNBAUM MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
NANCY J BROWN MD	DIRECTOR	1.00	Director	$0	$0	$0
RICHARD D DIMARCHI PHD	DIRECTOR	1.00	Director	$0	$0	$0
MARIA C FREIRE PHD	DIRECTOR	1.00	Director	$0	$0	$0
MATTIAS FYRENIUS	DIRECTOR	1.00	Director	$0	$0	$0
VERONIQUE KIERMER PHD	DIRECTOR	1.00	Director	$0	$0	$0
TONY HUNTER PHD	DIRECTOR	1.00	Director	$0	$0	$0
KIERSTEN STEAD PHD	DIRECTOR	1.00	Director	$0	$0	$0
LORI SUSSEL PHD	DIRECTOR	1.00	Director	$0	$0	$0
JOSEPH C WU MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
JULEEN R ZIERATH PHD	DIRECTOR	1.00	Director	$0	$0	$0
DEBORAH L JOHNSON PHD	PRESIDENT & CEO(THRU 9/24)	40.00	Officer Director	$359,088	$21,600	$380,688
MIKE PAGE	DIRECTOR(FROM 1/25)	1.00	Director	$0	$0	$0
TERRY L SHEPPARD PHD	EX-OFFICIO DIR/CHIEF SCIENCE OFFICER	40.00	Officer	$251,587	$23,563	$275,150
PAMELA DAUGHERTY	CHIEF FINANCIAL OFFICER	40.00	Officer	$187,551	$38,554	$226,105
MINDA MASON	SENIOR DIRECTOR OF DEVELOPMENT	40.00	Highest	$150,269	$19,115	$169,384
JOSH MAY	DIRECTOR, TECHNOLOGY & COMM.	40.00	Highest	$115,536	$17,060	$132,596
CHRIS HENRY	DIRECTOR OF OPERATIONS	40.00	Highest	$124,930	$7,473	$132,403

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$11,371,337	$12,895,876	$21,867,265	$-1,524,539
2024	$12,101,803	$12,109,586	$21,614,158	$-7,783
2023	$14,937,075	$13,247,202	$20,245,044	$1,689,873
2022	$9,290,392	$10,116,483	$18,786,234	$-826,091
2021	$7,402,542	$7,330,012	$19,886,137	$72,530
2020	$8,920,247	$10,191,632	$18,727,690	$-1,271,385
2019	$17,506,416	$15,696,676	$20,932,001	$1,809,740
2018	$14,838,421	$14,522,372	$18,728,860	$316,049

KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY